Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 58% ± 20% | |
lung | 11 studies | 34% ± 14% | |
eye | 7 studies | 34% ± 17% | |
heart | 6 studies | 53% ± 17% | |
peripheral blood | 5 studies | 33% ± 7% | |
kidney | 5 studies | 27% ± 9% | |
adipose | 4 studies | 39% ± 16% | |
liver | 4 studies | 41% ± 15% | |
intestine | 3 studies | 24% ± 3% | |
uterus | 3 studies | 27% ± 6% | |
breast | 3 studies | 27% ± 6% | |
skin | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 27751.97 | 2637 / 2642 | 100% | 207.10 | 705 / 705 |
ovary | 100% | 7817.45 | 180 / 180 | 97% | 15.19 | 419 / 430 |
lung | 99% | 12636.90 | 575 / 578 | 97% | 19.27 | 1116 / 1155 |
breast | 100% | 11712.71 | 458 / 459 | 96% | 18.23 | 1068 / 1118 |
skin | 99% | 8044.42 | 1791 / 1809 | 94% | 30.38 | 444 / 472 |
uterus | 99% | 7641.08 | 169 / 170 | 92% | 17.29 | 424 / 459 |
thymus | 99% | 6341.40 | 644 / 653 | 93% | 13.30 | 562 / 605 |
esophagus | 98% | 7184.19 | 1409 / 1445 | 92% | 18.68 | 168 / 183 |
kidney | 91% | 4586.79 | 81 / 89 | 95% | 24.17 | 856 / 901 |
bladder | 100% | 6746.76 | 21 / 21 | 81% | 11.59 | 407 / 504 |
prostate | 91% | 5096.15 | 224 / 245 | 86% | 9.54 | 432 / 502 |
adrenal gland | 99% | 6395.00 | 255 / 258 | 78% | 9.09 | 179 / 230 |
liver | 77% | 3071.16 | 173 / 226 | 82% | 10.27 | 332 / 406 |
intestine | 82% | 6585.93 | 795 / 966 | 44% | 5.14 | 234 / 527 |
stomach | 59% | 3660.82 | 213 / 359 | 66% | 8.79 | 188 / 286 |
pancreas | 21% | 755.51 | 69 / 328 | 89% | 13.76 | 159 / 178 |
adipose | 100% | 14182.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 18519.49 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 8334.94 | 1324 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 6749.96 | 239 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 18.19 | 44 / 45 |
heart | 97% | 14161.20 | 838 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 12.40 | 24 / 29 |
eye | 0% | 0 | 0 / 0 | 71% | 11.40 | 57 / 80 |
peripheral blood | 70% | 4258.49 | 648 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035886 | Biological process | vascular associated smooth muscle cell differentiation |
GO_1990764 | Biological process | myofibroblast contraction |
GO_0006397 | Biological process | mRNA processing |
GO_0042552 | Biological process | myelination |
GO_0051028 | Biological process | mRNA transport |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_1905869 | Biological process | negative regulation of 3'-UTR-mediated mRNA stabilization |
GO_0001570 | Biological process | vasculogenesis |
GO_0008380 | Biological process | RNA splicing |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0014004 | Biological process | microglia differentiation |
GO_0048710 | Biological process | regulation of astrocyte differentiation |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0008298 | Biological process | intracellular mRNA localization |
GO_0010717 | Biological process | regulation of epithelial to mesenchymal transition |
GO_0007286 | Biological process | spermatid development |
GO_0045649 | Biological process | regulation of macrophage differentiation |
GO_0017148 | Biological process | negative regulation of translation |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0160089 | Molecular function | internal N(7)-methylguanine-containing RNA reader activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | QKI |
Protein name | KH domain-containing RNA-binding protein QKI (Protein quaking) (Hqk) (HqkI) QKI, KH domain containing RNA binding |
Synonyms | HKQ |
Description | FUNCTION: RNA reader protein, which recognizes and binds specific RNAs, thereby regulating RNA metabolic processes, such as pre-mRNA splicing, circular RNA (circRNA) formation, mRNA export, mRNA stability and/or translation . Involved in various cellular processes, such as mRNA storage into stress granules, apoptosis, lipid deposition, interferon response, glial cell fate and development . Binds to the 5'-NACUAAY-N(1,20)-UAAY-3' RNA core sequence . Acts as a mRNA modification reader that specifically recognizes and binds mRNA transcripts modified by internal N(7)-methylguanine (m7G) . Promotes the formation of circular RNAs (circRNAs) during the epithelial to mesenchymal transition and in cardiomyocytes: acts by binding to sites flanking circRNA-forming exons . CircRNAs are produced by back-splicing circularization of pre-mRNAs . Plays a central role in myelinization via 3 distinct mechanisms . First, acts by protecting and promoting stability of target mRNAs such as MBP, SIRT2 and CDKN1B, which promotes oligodendrocyte differentiation (By similarity). Second, participates in mRNA transport by regulating the nuclear export of MBP mRNA (By similarity). Finally, indirectly regulates mRNA splicing of MAG pre-mRNA during oligodendrocyte differentiation by acting as a negative regulator of MAG exon 12 alternative splicing: acts by binding to HNRNPA1 mRNA splicing factor, preventing its translation (By similarity). Involved in microglia differentiation and remyelination by regulating microexon alternative splicing of the Rho GTPase pathway (By similarity). Involved in macrophage differentiation: promotes monocyte differentiation by regulating pre-mRNA splicing in naive peripheral blood monocytes . Acts as an important regulator of muscle development: required for the contractile function of cardiomyocytes by regulating alternative splicing of cardiomyocyte transcripts (By similarity). Acts as a negative regulator of thermogenesis by decreasing stability, nuclear export and translation of mRNAs encoding PPARGC1A and UCP1 (By similarity). Also required for visceral endoderm function and blood vessel development (By similarity). May also play a role in smooth muscle development . In addition to its RNA-binding activity, also acts as a nuclear transcription coactivator for SREBF2/SREBP2 (By similarity). .; FUNCTION: [Isoform QKI5]: Nuclear isoform that acts as an indirect regulator of mRNA splicing (By similarity). Regulates mRNA splicing of MAG pre-mRNA by inhibiting translation of HNRNPA1 mRNA, thereby preventing MAG exon 12 alternative splicing (By similarity). Involved in oligodendrocyte differentiation by promoting stabilization of SIRT2 mRNA (By similarity). Acts as a negative regulator of the interferon response by binding to MAVS mRNA, downregulating its expression . Also inhibits the interferon response by binding to fibrinectin FN1 pre-mRNA, repressing EDA exon inclusion in FN1 . Delays macrophage differentiation by binding to CSF1R mRNA, promoting its degradation . In addition to its RNA-binding activity, also acts as a nuclear transcription coactivator for SREBF2/SREBP2, promoting SREBF2/SREBP2-dependent cholesterol biosynthesis (By similarity). SREBF2/SREBP2-dependent cholesterol biosynthesis participates to myelinization and is required for eye lens transparency (By similarity). .; FUNCTION: [Isoform QKI6]: Cytosolic isoform that specifically recognizes and binds mRNA transcripts modified by internal N(7)-methylguanine (m7G) . Interaction with G3BP1 promotes localization of m7G-containing mRNAs into stress granules in response to stress, thereby suppressing their translation . Acts as a translational repressor for HNRNPA1 and GLI1 (By similarity). Translation inhibition of HNRNPA1 during oligodendrocyte differentiation prevents inclusion of exon 12 in MAG pre-mRNA splicing (By similarity). Involved in astrocyte differentiation by regulating translation of target mRNAs (By similarity). .; FUNCTION: [Isoform QKI7]: Cytosolic isoform that specifically recognizes and binds mRNA transcripts modified by internal N(7)-methylguanine (m7G) . Interaction with G3BP1 promotes localization of m7G-containing mRNAs into stress granules in response to stress, thereby suppressing their translation . Acts as a negative regulator of angiogenesis by binding to mRNAs encoding CDH5, NLGN1 and TNFAIP6, promoting their degradation . Can also induce apoptosis in the cytoplasm (By similarity). Heterodimerization with other isoforms results in nuclear translocation of isoform QKI7 and suppression of apoptosis (By similarity). Also binds some microRNAs: promotes stabilitation of miR-122 by mediating recruitment of poly(A) RNA polymerase TENT2, leading to 3' adenylation and stabilization of miR-122 . . |
Accessions | ENST00000545607.5 F5GXS8 ENST00000424802.7 [Q96PU8-5] ENST00000544436.5 ENST00000275262.11 [Q96PU8-6] ENST00000392127.6 [Q96PU8-8] Q96PU8 ENST00000361195.6 [Q96PU8-3] F5GYT7 H0YG47 ENST00000545346.1 ENST00000537124.5 ENST00000361758.8 [Q96PU8-9] ENST00000537041.5 ENST00000544361.1 ENST00000544823.5 ENST00000361752.8 [Q96PU8-1] ENST00000453779.6 [Q96PU8-9] F5GYM3 H0YGD6 H0YFB7 F5H5U6 ENST00000537883.5 F5H8C8 |